POSB160 Cost-Effectiveness of Dapagliflozin Compared to DPP-4 Inhibitors as Combination Therapy with Metformin in the Treatment of Type 2 Diabetes Mellitus without Established Cardiovascular Disease in Colombia.
Saved in:
| Title: | POSB160 Cost-Effectiveness of Dapagliflozin Compared to DPP-4 Inhibitors as Combination Therapy with Metformin in the Treatment of Type 2 Diabetes Mellitus without Established Cardiovascular Disease in Colombia. |
|---|---|
| Authors: | Gil Rojas, Y1 (AUTHOR), Lasalvia, P2 (AUTHOR), Garcia Peña, AA3 (AUTHOR) |
| Source: | Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS91-S92. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2021.11.433 |
